BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 30312482)

  • 1. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction.
    Gautschi F; Vogelmann T; Ortmanns G; Knörr F; Steinack C; Hage R; Nägeli M; Schuurmans MM
    J Clin Apher; 2024 Jun; 39(3):e22128. PubMed ID: 38829041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction.
    Benazzo A; Bagnera C; Ius F; Del Fante C; Gottlieb J; Hoetzenecker K; Meloni F; Jaksch P; Greer M
    Transpl Int; 2023; 36():11551. PubMed ID: 38282747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK).
    Fisher AJ; White M; Goudie N; Kershaw A; Phillipson J; Bardgett M; Lally J; Bevin-Nicholls A; Chadwick T; Bryant A; Russell S; Smith H; Frisby L; Errington R; Carby M; Thompson R; Santhanakrishnan K; Parmar J; Lordan JL; Vale L; Hancock H; Exley C; Gennery AR; Wason JM
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38724453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis.
    Bozzini S; Bozza E; Bagnera C; Del Fante C; Barone E; De Vitis S; De Amici M; Testa G; Croce S; Valsecchi C; Avanzini MA; Cacciatore R; Mortellaro C; Viarengo G; Perotti C; Meloni F
    J Transl Med; 2024 Mar; 22(1):276. PubMed ID: 38486224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome.
    Reschke R; Zimmerlich S; Döhring C; Behre G; Ziemer M
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009436
    [No Abstract]   [Full Text] [Related]  

  • 6. Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Hachem R; Corris P
    Transplantation; 2018 Jul; 102(7):1059-1065. PubMed ID: 29557913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments.
    Moosavi MM; Goodman AL; Duncan A; Stowell SR; Waller EK; Roback JD; Sullivan HC
    J Clin Apher; 2021 Feb; 36(1):34-40. PubMed ID: 32894888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
    Liu C; Shah K; Dynis M; Eby CS; Grossman BJ
    Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
    Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
    Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD).
    Afzal A; Tarbunova M; Despotis G; Grossman BJ
    Transfusion; 2020 Feb; 60(2):351-357. PubMed ID: 31919871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome.
    Karnes HE; Schindler EI; Morrell M; Hachem RR; Berman K; Vedantham S; Atkinson J; Spitznagel E; Despotis GJ
    Transplantation; 2019 May; 103(5):1036-1042. PubMed ID: 30130331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
    Chionis L; Grossman BJ; Hachem R; Commean P; Derfler MC; Vedantham S; Dodds K; Spitznagel E; Atkinson J; Despotis G
    Transfusion; 2018 Dec; 58(12):2933-2941. PubMed ID: 30312482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.